Discussing Cervical Cancer Screening Options: Outcomes to Guide Conversations Between Patients and Providers

Purpose. In 2018, the US Preventive Services Task Force (USPSTF) endorsed three strategies for cervical cancer screening in women ages 30 to 65: cytology every 3 years, testing for high-risk types of human papillomavirus (hrHPV) every 5 years, and cytology plus hrHPV testing (co-testing) every 5 yea...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:MDM Policy Pract
Main Authors: Holt, Hunter K., Kulasingam, Shalini, Sanstead, Erinn C., Alarid-Escudero, Fernando, Smith-McCune, Karen, Gregorich, Steven E., Silverberg, Michael J., Huchko, Megan J., Kuppermann, Miriam, Sawaya, George F.
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7440733/
https://ncbi.nlm.nih.gov/pubmed/32885045
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2381468320952409
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados